Raymond R. Mandra
Partner, New York
Professional Experience
Raymond R. Mandra is the Chair of the firm’s Biotechnology Practice Group.
He joined Fitzpatrick, Cella, Harper & Scinto in 1989. Since that time he has concentrated in the areas of patent counseling, application writing, prosecution, litigation, licensing and due diligence primarily involving the chemical, food, pharmaceutical and biotechnological sciences.
Mr. Mandra has prepared numerous chemical, pharmaceutical and food related patent applications for various clients, including Warner Chilcott, Genzyme, Mars Incorporated, Pfizer, Novartis, Bristol-Myers Squibb, Leo Pharma Inc and Astellas Pharma Inc. Mr. Mandra has extensive experience in the prosecution of both U.S. patent applications and international patent applications under the Patent Cooperation Treaty. He has also been substantially involved in various patent litigations, reexaminations and reissues.
Prior to joining Fitzpatrick, Cella, Harper & Scinto, Mr. Mandra worked for nine years as a chemist for the General Foods Corporation.
Awards and Recognition
Mr. Mandra was listed in Legal 500 2007, 2008, and 2009 in Patent Litigation. He was also listed as a Leading Lawyer in Legal 500 2008 for Patent Re-examination.
For information on the selection process, see:
http://www.legal500.com/index.php?option=com_content&task=view&id=772&Itemid=1
Education
J.D., magna cum laude, Pace University, Research and Writing Editor on the Pace Law Review, 1990
M.S. Chemistry, Long Island University, 1985
B.S. Chemistry, State University of New York at Oswego, 1979
Bar Admissions
State of New York, 1991; State of Connecticut, 1990; U.S. Court of Appeals for the Federal Circuit; U.S. District Courts for the Southern and Eastern Districts of New York; U.S. Patent and Trademark Office
Professional Activities
American Bar Association; American Intellectual Property Law Association; New York Intellectual Property Law Association
Related Information
Publications
-
Supporting Patentability With Commercial Success
Law 360
September 24, 2009 -
Stem Cells and Patenting and Related Regulatory Issues: A United States Perspective
Bio-Science Law Review
September/October 2005
Events
-
12th Advanced Forum on Biotech Patents Conference
American Conference Institute
November 30 - December 1, 2010 -
Follow On Biologics Conference
American Conference Institute
June 21-22, 2010 -
18th Annual C5 Forum on Biotech Patenting
C5
March 17-19, 2010 -
5th Annual Developing IP Strategies for Crystalline Forms Conference
IQPC
November 9-11, 2009 -
Highlighting In-Depth Interference Practices, Patent Life Cycle Management and Litigation Tactics
IQPC's 2nd Annual Patent Strategies for the Pharma, Biotech and Medical Device Industries
July 15-16, 2008 -
Best Practices for Evaluating Your Infringement Risk and Interpreting the Claims
C5's 5th Annual International Freedom to Operate Forum
June 10, 2008 -
Eyes Wide Open: What You Must Do to See Beyond the Veil (FTO in the Wider Context)
C5 4th International FTO Forum
March 29, 2007 -
Due Diligence Required Prior to Licensing a Pharmaceutical Candidate
C5 BioPharm Licensing Conference
December 6, 2006 -
Recent Reforms in PCT Practice
New York Intellectual Property Law Association Fall CLE Program
November 21, 2003 -
Compliance with the Written Description Requirement
AIPLA's Advanced Patent Prosecution Training Seminar
June 12, 2003 -
Claim Construction, Anticipation and Section 112 Issues
NYIPLA CLE Luncheon
March 28, 2003
In The News
-
Prolonging Patent: Under Wyeth, Many Patent Terms Will Be Recalculated
Inside Counsel
April 2010
- E rmandra@fchs.com
- T (212) 218-2235
- F (212) 218-2200
- Outlook vCard
- E-mail this page
- Print PDF (Short Bio)
-
